Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 46 | $77,547,686 |
Sells | 105 | $271,574,864 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
23 Aug 2024 18:38 | SPRY | ARS Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director | 23 Aug 2024 | Sale | 69,500 | 13.03 | 905,585 | I |
29 Jun 2023 16:46 | ACET | Adicet Bio Inc | ORBIMED ADVISORS LLC | Director , 10% | 27 Jun 2023 | Purchase | 442,000 | 2.09 | 923,780 | I |
15 May 2023 18:07 | VRNA | Verona Pharma plc | ORBIMED ADVISORS LLC | Director | 12 May 2023 | Sale | 43,200 | 21.64 | 934,848 | I |
28 Dec 2022 17:57 | TERN | Terns Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director , 10% | 23 Dec 2022 | Purchase | 137,931 | 7.25 | 1,000,000 | I |
09 Nov 2022 16:25 | THRX | Theseus Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director , 10% | 07 Nov 2022 | Purchase | 192,000 | 5.21 | 1,000,320 | I |
19 Jul 2023 16:15 | THRX | Theseus Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director , 10% | 17 Jul 2023 | Purchase | 328,482 | 3.05 | 1,001,870 | I |
20 Jun 2024 17:19 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 17 Jun 2024 | Purchase | 28,404 | 36 | 1,022,544 | I |
28 Aug 2024 16:26 | SPRY | ARS Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director | 26 Aug 2024 | Sale | 83,695 | 13 | 1,088,035 | I |
25 Nov 2022 20:13 | TCDA | Tricida Inc | ORBIMED ADVISORS LLC | Director , 10% | 23 Nov 2022 | Sale | 5,617,300 | 0.21 | 1,179,633 | I |
02 May 2023 21:34 | KNTE | Kinnate Biopharma Inc | ORBIMED ADVISORS LLC | Director , 10% | 01 May 2023 | Purchase | 467,068 | 2.62 | 1,223,718 | I |
21 Apr 2023 17:08 | TELA | TELA Bio Inc | ORBIMED ADVISORS LLC | 10% | 19 Apr 2023 | Sale | 136,000 | 9.3 | 1,264,800 | I |
10 Nov 2022 16:44 | CMPX | Compass Therapeutics Inc | ORBIMED ADVISORS LLC | Director , 10% | 08 Nov 2022 | Purchase | 402,000 | 3.21 | 1,290,420 | I |
15 Aug 2024 17:01 | KROS | Keros Therapeutics Inc | ORBIMED ADVISORS LLC | Director | 13 Aug 2024 | Sale | 29,400 | 44.01 | 1,293,894 | I |
17 Feb 2023 16:43 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director , 10% | 15 Feb 2023 | Purchase | 57,318 | 23 | 1,318,314 | I |
08 May 2023 17:22 | KNTE | Kinnate Biopharma Inc | ORBIMED ADVISORS LLC | Director , 10% | 05 May 2023 | Purchase | 490,511 | 2.82 | 1,383,241 | I |
08 May 2023 17:22 | KNTE | Kinnate Biopharma Inc | ORBIMED ADVISORS LLC | Director , 10% | 05 May 2023 | Purchase | 490,512 | 2.82 | 1,383,244 | I |
20 Jun 2024 17:19 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 17 Jun 2024 | Purchase | 43,944 | 36 | 1,581,984 | I |
15 May 2023 18:07 | VRNA | Verona Pharma plc | ORBIMED ADVISORS LLC | Director | 11 May 2023 | Sale | 80,000 | 22.26 | 1,780,800 | I |
02 Jul 2024 16:54 | TELA | TELA Bio Inc | ORBIMED ADVISORS LLC | 10% | 28 Jun 2024 | Sale | 378,000 | 4.74 | 1,791,720 | I |
15 Aug 2024 16:51 | SCPH | scPharmaceuticals Inc | ORBIMED ADVISORS LLC | 10% | 13 Aug 2024 | Purchase | 478,342 | 4 | 1,913,368 | I |
14 Dec 2023 17:44 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 13 Dec 2023 | Sale | 36,400 | 58.56 | 2,131,584 | I |
27 Dec 2022 17:38 | VRNA | Verona Pharma plc | ORBIMED ADVISORS LLC | Director | 23 Dec 2022 | Sale | 92,992 | 24.11 | 2,242,037 | I |
26 Jan 2024 19:14 | ACET | Adicet Bio Inc | ORBIMED ADVISORS LLC | Director , 10% | 25 Jan 2024 | Purchase | 1,041,700 | 2.4 | 2,500,080 | I |
29 Dec 2023 16:18 | ALPN | ALPINE IMMUNE SCIENCES Inc | ORBIMED ADVISORS LLC | Director | 28 Dec 2023 | Sale | 139,166 | 18.32 | 2,549,521 | I |
31 Aug 2023 17:26 | SPRY | ARS Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director | 29 Aug 2023 | Purchase | 500,000 | 6.2 | 3,100,000 | I |
15 Dec 2023 18:04 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 14 Dec 2023 | Sale | 57,100 | 56.75 | 3,240,425 | I |
29 Dec 2023 16:18 | ALPN | ALPINE IMMUNE SCIENCES Inc | ORBIMED ADVISORS LLC | Director | 27 Dec 2023 | Sale | 162,576 | 19.96 | 3,245,017 | I |
14 Dec 2023 17:44 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 13 Dec 2023 | Sale | 56,200 | 58.56 | 3,291,072 | I |
31 Jan 2024 16:12 | AVBP | ArriVent Biopharma Inc | ORBIMED ADVISORS LLC | Director , 10% | 30 Jan 2024 | Purchase | 222,222 | 18 | 3,999,996 | I |
31 Jan 2024 16:12 | AVBP | ArriVent Biopharma Inc | ORBIMED ADVISORS LLC | Director , 10% | 30 Jan 2024 | Purchase | 222,222 | 18 | 3,999,996 | I |
17 Sep 2024 20:13 | MBX | MBX Biosciences Inc | ORBIMED ADVISORS LLC | Director , 10% | 16 Sep 2024 | Purchase | 250,000 | 16 | 4,000,000 | I |
29 Nov 2022 16:36 | SCPH | scPharmaceuticals Inc | ORBIMED ADVISORS LLC | 10% | 25 Nov 2022 | Purchase | 762,380 | 5.25 | 4,002,495 | I |
26 Jan 2024 19:14 | ACET | Adicet Bio Inc | ORBIMED ADVISORS LLC | Director , 10% | 25 Jan 2024 | Purchase | 1,841,100 | 2.4 | 4,418,640 | I |
24 Jul 2023 16:38 | TSBX | Turnstone Biologics Corp | ORBIMED ADVISORS LLC | Director , 10% | 20 Jul 2023 | Purchase | 416,666 | 12 | 4,999,992 | I |
25 Jan 2024 16:28 | EWTX | Edgewise Therapeutics Inc | ORBIMED ADVISORS LLC | Director , 10% | 23 Jan 2024 | Purchase | 454,545 | 11 | 4,999,995 | I |
24 May 2023 17:09 | PRLD | Prelude Therapeutics Inc | ORBIMED ADVISORS LLC | Director , 10% | 22 May 2023 | Purchase | 869,565 | 5.75 | 4,999,999 | I |
23 Aug 2024 18:38 | SPRY | ARS Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director | 22 Aug 2024 | Sale | 391,482 | 12.94 | 5,065,777 | I |
21 Sep 2022 18:00 | THRD | Third Harmonic Bio Inc | ORBIMED ADVISORS LLC | Director , 10% | 19 Sep 2022 | Purchase | 300,000 | 17 | 5,100,000 | I |
23 Aug 2024 18:38 | SPRY | ARS Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director | 21 Aug 2024 | Sale | 394,400 | 13.52 | 5,332,288 | I |
15 Apr 2024 17:25 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 11 Apr 2024 | Sale | 461,899 | 14.49 | 6,692,917 | I |
15 May 2023 18:07 | VRNA | Verona Pharma plc | ORBIMED ADVISORS LLC | Director | 15 May 2023 | Sale | 345,313 | 20 | 6,906,260 | I |
17 Sep 2024 20:13 | MBX | MBX Biosciences Inc | ORBIMED ADVISORS LLC | Director , 10% | 16 Sep 2024 | Purchase | 500,000 | 16 | 8,000,000 | I |
15 Dec 2023 18:04 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 14 Dec 2023 | Sale | 147,600 | 56.75 | 8,376,300 | I |
15 Aug 2024 17:01 | KROS | Keros Therapeutics Inc | ORBIMED ADVISORS LLC | Director | 13 Aug 2024 | Sale | 220,600 | 44.01 | 9,708,606 | I |
15 Dec 2023 18:04 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 14 Dec 2023 | Sale | 228,500 | 56.75 | 12,967,375 | I |
27 Dec 2022 17:38 | VRNA | Verona Pharma plc | ORBIMED ADVISORS LLC | Director | 22 Dec 2022 | Sale | 684,696 | 22.07 | 15,111,241 | I |
27 Dec 2022 17:38 | VRNA | Verona Pharma plc | ORBIMED ADVISORS LLC | Director | 23 Dec 2022 | Sale | 961,328 | 22.27 | 21,408,775 | I |
29 Dec 2023 16:18 | ALPN | ALPINE IMMUNE SCIENCES Inc | ORBIMED ADVISORS LLC | Director | 28 Dec 2023 | Sale | 1,195,683 | 18.32 | 21,904,913 | I |
20 May 2024 17:00 | ELVN | Enliven Therapeutics Inc | ORBIMED ADVISORS LLC | Director , 10% | 16 May 2024 | Sale | 1,000,000 | 22.14 | 22,140,000 | I |
27 Dec 2022 17:38 | VRNA | Verona Pharma plc | ORBIMED ADVISORS LLC | Director | 23 Dec 2022 | Sale | 1,116,048 | 23.23 | 25,925,795 | I |
27 Dec 2022 17:38 | VRNA | Verona Pharma plc | ORBIMED ADVISORS LLC | Director | 22 Dec 2022 | Sale | 3,284,800 | 21.71 | 71,313,008 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)